Gurgaon Samachar

AUTHOR CARL BURTON & PYROCHILL ON FIRE

 Breaking News
  • No posts were found

AUTHOR CARL BURTON & PYROCHILL ON FIRE

December 24
22:27 2019
FIRST FIDELITY TRUST & BANCORP (Colorado) names best selling author Carl Burton as Director of Sales and Marketing to its PYROCHILL division.

Detroit, Michigan – December 24, 2019 – First Fidelity Trust & Bancorp a financial consortium based in the state of Colorado announced today that it has appointed Carl Burton of Detroit, Mi. as its Director of Sales and Marketing. Burton, the best selling author of “Thoughts of An Unlikely Messenger” will head the sales and marketing division of SIPP’s fully developed product line known as “PYROCHILL.“

First Fidelity USA, Inc., dba First Fidelity Trust & Bancorp (Colorado) is a financial consortium and major shareholder of SIPP International Industries, Inc. (trading symbol SIPN) “We are truly excited having Carl on our team. Its not every day that a developement stage company lands an accomplished author and marketing guru like Carl,” says Chris Fascenelli, First Fidelity’s President. Burton has stated …. “I asked God if he existed and he answered. When I became a man, I asked God for the truth. What he showed me made me look at life, history, and what’s going on in the world differently.” PYROCHILL relates to every word Burton has penned.

PYROCHILLFIRE INHIBITOR is a non toxic, bio-degradable fire inhibitor. What ever material treated with PYROCHILL will never combust into flames. PYROCHILL prevents the spread of fire and minimizes fire damage. Unlike most flame retardants that only delays the amount of time before something catches on fire, PYROCHILL stops fire dead.

Safe Harbor Statement:

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

If you’d like more information about this topic, please call Denise Sullivan at First Fidelity USA, Inc. (855)797-6244.

Media Contact
Company Name: First Fidelity Trust & Bancorp
Contact Person: Media Manager
Email: Send Email
City: Detroit
State: Michigan
Country: United States
Website: http://www.firstfidelityusa.com/

Recent Posts

Generalized Myasthenia Gravis Market and Epidemiology Forecast 2032: Drugs, Companies, by DelveInsight | Viela Bio, UCB Pharma, Ra Pharma, Argenx, Alexion Pharma, Takeda, Hoffmann-La Roche

Read Full Article

Categories